Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 4
Background:Soft neurological symptoms have been observed in patients with schizophrenia. Several studies have shown neurological abnormalities in schizophrenia patients, but their presence has been complicated by a number of potentially confounding variables such as the duration of the illness, drug doses, and the use of diverse assessment methodologies. Soft neurological symptoms appear to be a characteristic component of schizophrenia as well as a probable biological indication of prognosis. As a result, early detection and action may result in a better prognosis. The assessment of soft neurological symptoms is a straightforward, simple, and low-cost method of determining the severity of brain dysfunction in schizophrenia. The relationship between the presence of schizophrenia and soft neurological symptoms in a patient has not been widely examined in the context of the Indian population. As a result, the purpose of this study is to assess the presence of mild neurological symptoms in individuals with schizophrenia.